The firm's revenues were up 28 percent, but its increased expenses — including costs associated with defending litigation brought by Eppendorf — pushed its net loss up sharply for the quarter.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.